John Dombrowski
Papers
1
Total Citations
128
H-Index
1
About
Dr. John Dombrowski is a leading radiation oncologist whose research has fundamentally advanced the treatment of prostate cancer through stereotactic body radiation therapy (SBRT). His most impactful work centers on demonstrating that extreme hypofractionation—delivering very high radiation doses in fewer sessions—can be both safe and effective for low- and intermediate-risk prostate cancer. His landmark multicenter trial, cited over 128 times, provided critical evidence that dose-escalated SBRT could be administered safely across multiple institutions, establishing a new standard of care that spares patients weeks of conventional treatment. This work directly challenged traditional radiobiology assumptions by proving that prostate cancer is uniquely sensitive to these ultra-high dose-per-fraction regimens. Dr. Dombrowski’s contributions have not only improved patient convenience and quality of life but have also reshaped clinical guidelines worldwide. His rigorous multicenter data remain essential reading for any clinician or researcher exploring hypofractionation, and his ongoing work continues to refine the balance between tumor control and toxicity in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1